Iclazepam
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
7-chloro-1-[2-(cyclopropylmethoxy)ethyl]-5-phenyl-3H-1,4-benzodiazepin-2-one | |
| Identifiers | |
| CAS Number |
57916-70-8 |
| PubChem | CID 68777 |
| ChemSpider |
62020 |
| UNII |
FL061Q6NMC |
| ChEMBL | CHEMBL2104257 |
| Chemical data | |
| Formula | C21H21ClN2O2 |
| Molar mass | 368.857 g/mol |
| |
| |
| (verify) | |
Iclazepam (Clazepam) is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and is around the same potency as chlordiazepoxide.
Iclazepam is a derivative of nordazepam substituted with a cyclopropylmethoxyethyl group on the N1 nitrogen. Once in the body, iclazepam is quickly metabolised to nordazepam and its N-(2-hydroxyethyl) derivative, which are thought to be mainly responsible for its effects.[1]
See also
References
- ↑ Giudicelli JF, Berdeaux A, Idrissi N, Richer C. Clazepam: pharmacokinetics and effects on performance. British Journal of Clinical Pharmacology. 1978 Jan;5(1):65-9.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
